Skip to main content
SHIFT Newsroom
Read the latest published stories →Medicine news and evidence →

Wegovy eligibility for UK men: NHS BMI rules and the two year cap

Published 11 October 2026 · SHIFT Team

Wegovy eligibility article title card

You're likely eligible for Wegovy if your BMI is 35 or above with a weight-related health condition, or 30 to 34.9 with specialist-referral criteria, and you can access it through an NHS specialist weight-management service or a private prescription after a clinician consultation. Treatment runs for a maximum of 2 years, and it's not suitable during pregnancy.

TL;DR:

- NICE lowers BMI thresholds by about 2.5 kg/m² for several ethnic groups, while clinicians also consider waist size, health, age, and frailty.
- NHS prescriptions come through specialist tier 3 or tier 4 services, not usually GPs; local capacity varies, and waiting times have no national figure.
- Private treatment requires assessment by a registered prescriber and dispensing through a regulated pharmacy; services that skip consultation or hide credentials are red flags.
- After 6 months on the maintenance dose, NHS teams may stop treatment if weight loss is under 5%; treatment is capped at 2 years.
- Wegovy is unsuitable during pregnancy or breastfeeding, and people who could become pregnant are advised to use reliable contraception during treatment.

Table of Contents

Who is eligible for Wegovy on the NHS: exact criteria and ethnic adjustments

NICE recommends semaglutide (branded as Wegovy) within specialist weight-management services for adults with a BMI of 35 or above who also have at least one weight-related health condition. Adults with a BMI between 30 and 34.9 can also qualify, but only if they meet the specific criteria set for referral into a specialist service rather than general practice.

The comorbidity requirement matters as much as the BMI figure itself. Common qualifying conditions include:

NICE also builds in ethnic adjustments to the BMI thresholds, typically lowering them by around 2.5 kg/m² for people from South Asian, Chinese, other Asian, Middle Eastern, Black African and African-Caribbean backgrounds. This reflects the fact that these groups tend to carry higher health risks at a lower BMI than White European populations, so the standard cut-offs would otherwise under-identify people who could benefit.

BMI alone is a blunt measure. NHS guidance notes that clinicians weigh it alongside waist measurements and overall health, which is worth knowing if you're a man with a higher muscle mass wondering why the numbers don't quite tell your story. Most services also set an age floor of 18, and some apply upper age or frailty exclusions depending on local policy.

BMI waist and health factors in eligibility assessment

How to access Wegovy on the NHS: GP, referral, tiers, waiting lists and pilots

Your GP is the starting point, but not the endpoint. GPs rarely issue Wegovy prescriptions directly for weight management. Instead, their job is to assess your history, confirm your BMI and comorbidities, and refer you onward.

  1. Book a GP appointment and bring a recent, accurate weight and BMI record.
  2. Be ready to discuss any weight-related conditions and previous attempts at structured weight-loss programmes, such as dietitian support or NHS-run courses.
  3. Your GP refers you to a specialist tier 3 or tier 4 weight-management service, which is usually hospital-based.
  4. The specialist team reviews your case against NICE criteria and decides whether to prescribe.

These specialist services are the only part of the NHS authorised to prescribe Wegovy for weight management, and local interim policy statements from integrated care boards explicitly instruct primary care not to prescribe it. Capacity varies a great deal by postcode, and waiting lists at specialist services can be long, something government-backed pilot schemes are trying to ease through community and digital delivery models. Whether that reaches your area yet depends on local commissioning decisions.

Pro Tip: Ask your GP practice whether your local integrated care board has published its own weight-management referral pathway, since the criteria and paperwork can differ slightly between areas.

If you want to understand how a GP referral compares with going straight to a specialist route, our GP versus specialist weight-management guide sets out the practical differences.

Wegovy is a prescription-only medicine in the UK, and it's never legitimately sold over the counter. Going private doesn't bypass the clinical checks, it just changes who performs them and how quickly you can start.

A properly run private pathway includes:

Many patients care about legitimacy and check who's actually behind a prescription, which is a sensible instinct: MHRA approval updates only cover medicines dispensed through regulated channels, with the dose and monitoring decisions made by a named prescriber. If a service skips the consultation, won't name or show the credentials of the prescriber, or offers to post medication with no clinical review, treat that as a red flag and look elsewhere.

Treatment length, dosing highlights, stopping rules and side effects you need to know

Wegovy is started at a low dose and increased gradually over several weeks, following the schedule your prescriber sets, up to a maintenance dose that may now go as high as 72 mg following recent MHRA authorisation. Within NHS specialist services, NICE sets a maximum treatment period of 2 years.

There's also a clear checkpoint built into the pathway: if you haven't lost at least 5% of your starting weight after 6 months on the maintenance dose, your clinical team will typically review your treatment and may stop it. That's not a punishment, it's how the NHS keeps a limited-capacity service focused on people the medicine is clearly helping. Our guide on preparing for a treatment review covers what that conversation usually looks like.

Key safety points to know before starting:

Any suspected side effect, especially an unexpected or serious one, can and should be reported through the Yellow Card scheme, the MHRA's official reporting channel for medicine safety.

What clinicians assess and how monitoring works in specialist services

Before prescribing, a clinician checks your cardiovascular risk, any history of pancreatitis, your current medications for interactions, and, where relevant, confirms you're not pregnant. This isn't paperwork for its own sake, it's the safety gate that decides whether Wegovy is appropriate for you specifically.

Once you're on treatment, ongoing monitoring typically includes:

Pro Tip: Keep a simple weekly note of your weight and any side effects, it makes follow-up appointments faster and gives your clinician a clearer picture than memory alone.

Medication is one part of a bigger plan. Specialist services pair it with dietary support, activity guidance and behavioural change work, because the evidence behind Wegovy's results comes from trials where it was used alongside lifestyle support, not instead of it. If the medicine isn't working, or side effects become unmanageable, your team will stop treatment and may report significant reactions via Yellow Card.

How we support men through eligibility and treatment

We offer support to men to help them check their likely eligibility and provide structured assistance once treatment starts. Our GLP-1 Knowledge Centre is a good next stop if you want to read more before deciding anything.

How we can help you check eligibility and get started

Figuring out whether you qualify, and which route makes sense, is where most men get stuck. We help you work through that with an eligibility check and a consultation with a regulated prescribing partner, so you know where you stand before you commit to anything.

Shift Some Timber Ltd

What that looks like in practice:

If diet support alongside medication is something you want to explore, partners like Nutrilike offer personalised nutrition planning that can sit alongside a weight-management programme. For costs and what to budget for a private pathway, our Wegovy cost guide breaks it down. When you're ready, our Weight-Loss Decision Centre is the clearest place to start working out your next step.

This article is general information, not a substitute for advice from a qualified doctor. Consult a qualified healthcare professional about your own circumstances before acting on anything here.

FAQ

What are the NHS eligibility criteria for Wegovy in 2026?

You need a BMI of 35 or above with at least one weight-related health condition, or a BMI of 30 to 34.9 if you meet specialist-referral criteria, under NICE guidance. Lower BMI thresholds, typically around 2.5 kg/m² less, apply for some ethnic groups, and prescribing only happens within specialist tier 3 or tier 4 services.

What are the NHS criteria for getting Wegovy?

The core requirement is a qualifying BMI alongside a relevant comorbidity, such as type 2 diabetes, high blood pressure or severe sleep apnoea, assessed by a specialist weight-management service rather than a GP. NICE also limits NHS use to a maximum of 2 years, with a review at 6 months to check you've lost at least 5% of your starting weight.

Can a GP prescribe Wegovy UK?

GPs generally don't prescribe Wegovy directly for weight management. Instead, NHS guidance and local interim policies point to specialist tier 3 and tier 4 services as the only NHS route, with your GP handling the initial assessment and referral.

How long is the NHS waiting list for Wegovy?

Waiting times vary significantly by area because specialist service capacity differs between integrated care boards, and demand regularly outstrips places. Government-backed pilot schemes are testing community and digital models to ease this, but there's no single national waiting-time figure to quote.

Sources